Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant

NCT03131934 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT03131934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03131934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant
Lead sponsor
University College, London
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2019
Completion date
March 12, 2026
Enrollment
4 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

post-transplant lymphoproliferative disease, transplant-related hematologic malignancy